{{Drugbox
| verifiedrevid = 447830929
| IUPAC_name = Ethyl 4-(3-hydroxyphenyl)-1-methyl-piperidine-4-carboxylate
| image = hydroxypethidine.svg
| width = 160

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = Schedule I
| legal_UK = <!-- Class A -->
| legal_US = Schedule I
| legal_DE = Anlage I
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number = 468-56-4
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 61120
| ChEMBL = 1182665
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 55068
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = W1J43H2B3K

<!--Chemical data-->
| C=15 | H=21 | N=1 | O=3 
| molecular_weight = 263.332 g/mol
| smiles = O=C(OCC)C2(c1cccc(O)c1)CCN(C)CC2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C15H21NO3/c1-3-19-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = WTJBNMUWRKPFRS-UHFFFAOYSA-N
}}

'''Hydroxypethidine''' ('''Bemidone''') is an [[opioid]] [[analgesic]] that is an [[analog (chemistry)|analogue]] of [[pethidine]] (meperidine). Hydroxypethidine is significantly less potent than meperidine as an analgesic, (0.3x meperidine in potency) although it also has [[NMDA antagonist]] properties like its close relative [[ketobemidone]].<ref> Isbell Harris. The addiction liability of some analogues of meperidine. Journal of Pharmacology And Experimental Therapeutics, 1949; 97(2): 182-190 </ref>

Hydroxypethidine has similar effects to other opioids, and produces analgesia, sedation and euphoria. Side effects can include [[itching]], [[nausea]] and potentially serious [[respiratory depression]] which can be life-threatening.

Hydroxypethidine is under international control under the Single Convention on Narcotic Drugs 1961 and therefore controlled like morphine in most countries; in the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9627 and a 2014 annual aggregate manufacturing quota of 2 grammes. The salt in use is the hydrochloride, with a free base conversion ratio of 0.878. <ref>http://www.deadiversion.usdoj.gov/quotas/conv_factor/index.html</ref>

==See also==
* [[4-Fluoropethidine|4-Fluoromeperidine]]

== References ==
{{Reflist|1}}

{{Opioidergics}}

[[Category:Synthetic opioids]]
[[Category:Piperidines]]
[[Category:Phenols]]
[[Category:Carboxylate esters]]
[[Category:Mu-opioid agonists]]


{{analgesic-stub}}